Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and glycopyrrolate for catheter-related bladder discomfort
NCT05013320Withdrawn
- Sponsor
- Kangbuk Samsung Hospital
- Start
- Sep 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
01
Overview
Randomised, triple-blind trial of glycopyrronium in cystitis, sponsored by Kangbuk Samsung Hospital. Primary endpoint: Incidence of catheter-related bladder discomfort at 0 months. Planned start Sep 2021; status: withdrawn.
02
Drugs
glycopyrronium
03
Conditions
cystitis
Beyond the preview
Go deeper on NCT05013320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05013320.